A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Elimination
Based on the social media company, the service has taken down problematic content and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at home.
Within moments of entering one community, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Item Information and Costs
Within these communities, messages show black plastic parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially significant medical dangers”.
